The history and market impact of CRISPR RNA-guided nucleases
| dc.contributor.author | van Erp, Paul B. G. | |
| dc.contributor.author | Bloomer, Gary | |
| dc.contributor.author | Wilkinson, Royce A. | |
| dc.contributor.author | Wiedenheft, Blake A. | |
| dc.date.accessioned | 2016-05-26T13:55:06Z | |
| dc.date.available | 2016-05-26T13:55:06Z | |
| dc.date.issued | 2015-06 | |
| dc.identifier.citation | Van Erp, Paul BG, Gary Bloomer, Royce Wilkinson, and Blake Wiedenheft. “The History and Market Impact of CRISPR RNA-Guided Nucleases.” Current Opinion in Virology 12 (June 2015): 85–90. doi:10.1016/j.coviro.2015.03.011. | en_US |
| dc.identifier.issn | 1879-6257 | |
| dc.identifier.uri | https://scholarworks.montana.edu/xmlui/handle/1/9879 | |
| dc.description.abstract | The interface between viruses and their hosts’ are hot spots for biological and biotechnological innovation. Bacteria use restriction endonucleases to destroy invading DNA, and industry has exploited these enzymes for molecular cut-and-paste reactions that are central to many recombinant DNA technologies. Today, another class of nucleases central to adaptive immune systems that protect bacteria and archaea from invading viruses and plasmids are blazing a similar path from basic science to profound biomedical and industrial applications. | en_US |
| dc.description.sponsorship | National Institutes of Health (P20GM103500 and R01GM108888), the National Science Foundation EPSCoR (EPS-110134), the M.J. Murdock Charitable Trust, and the Montana State University Agricultural Experimental Station | en_US |
| dc.rights | You are free to: Share — copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/legalcode | en_US |
| dc.title | The history and market impact of CRISPR RNA-guided nucleases | en_US |
| dc.type | Article | en_US |
| mus.citation.extentfirstpage | 85 | en_US |
| mus.citation.extentlastpage | 90 | en_US |
| mus.citation.journaltitle | Current opinion in virology | en_US |
| mus.citation.volume | 12 | en_US |
| mus.identifier.category | Life Sciences & Earth Sciences | en_US |
| mus.identifier.doi | 10.1016/j.coviro.2015.03.011 | en_US |
| mus.relation.college | College of Agriculture | en_US |
| mus.relation.college | College of Letters & Science | en_US |
| mus.relation.department | Microbiology & Immunology. | en_US |
| mus.relation.university | Montana State University - Bozeman | en_US |
| mus.data.thumbpage | 3 | en_US |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.